Drugs in the Pipeline--An R&D Analysis (Technical Insights)

 


This research service profiles and analyzes drug discovery and development efforts, with specific reference to the cardiology, central nervous system, and cancer therapeutic sectors. We also feature some new approaches and enabling technologies for drug discovery and development. The research service identifies some important clinical trials in the therapeutic areas that fall within the scope of the research.

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

Table of Contents

Drugs in the Pipeline--An R&D Analysis (Technical Insights), Executive SummaryIntroductionThe Drug Discovery ProcessPre-Clinical StudiesOverview of Clinical Trials Scope and MethodologyScope and SegmentationMethodologyDrugs in the Pipeline--An R&D Analysis (Technical Insights), Market- and Technology-based AnalysisChallenges; Drivers; RestraintsDrug Discovery Technology RestraintsDrug Discovery Market RestraintsTechnology and Market DriversProfiles of Drug Development Industry Partnerships and Collaborations - IProfiles of Drug Development Industry Partnerships and Collaborations - IIProfiles of Drug Development Industry Partnerships and Collaborations - IIINew Technologies and Research Related Impacting Drug DiscoveryMicrodosing Accelerates Early-Phase Drug DevelopmentUsing Nanotechnology to Enhance the Pharmacological Profile and Extend Exclusivity of DrugsHuman Drug Absorption Studies Enhance Candidate SelectionDrug Distribution Studies Use Gamma ScintigraphyAdvances in Drug Delivery--Injection Technologies; Inhalation DeliveryAdvances in Drug Delivery--Targeted Delivery; Liposomes; MicroencapsulationAdvances in Drug Delivery--Polymers; Nanotechnology-MEMS-Microchips Dynamic Combinatorial ChemistryRationalization of Target Selection Drugs in the Pipeline--An R&D Analysis (Technical Insights), Drugs in the Pipeline for the Cardiovascular SystemCardiovascular Therapeutics Research in the UniversitiesGene Linked to Coronary Artery Disease and Myocardial Infarction DiscoveredBlood Protein's Link to Heart Disease Corporate Research in Cardiovascular Therapeutics deCODE genetics Finds Heart Attack Risk GeneHedgehog Gene for Easing Heart AttackNicotine Boosts Stem Cell ProductionCelera Finds Heart Attack MarkerDrugs in The Pipeline for Cardiovascular DisordersOverview of Cardiovascular DisordersDrugs in the Pipeline for Heart FailureDrugs in the Pipeline for HypertensionDrugs in the Pipeline for Coronary ThrombosisDrugs in the Pipeline for ArrhythmiaDrugs in the Pipeline for Deep Vein ThrombosisDrugs in the Pipeline for Ischemic StrokeDrugs in the Pipeline for Coronary Artery DiseaseDrugs in the Pipeline for DyslipidemiaDrugs in the Pipeline for AnginaDrugs in the Pipeline for Myocardial InfarctionAdjunctive TherapiesDrugs in the Pipeline--An R&D Analysis (Technical Insights), Drugs in the Pipeline for the Central Nervous SystemCorporate Research in CNS TherapeuticsAGY Therapeutics Finds Cathepsin B in Alzheimer'sBAFF Structure Aids Xencor Anti-TNF Agent SearchNexia Nerve Protection Agent Meets Army ObjectiveRepligen Autism Clinical Does Not Meet EndpointsdeCode Begins Study of Autism GeneticsDepression/Anxiety Drug Milestone for NeurogenMorphoSys Antibodies Hit Alzheimer’s Brain TargetTargacept Finds Alzheimer’s Cell Death GeneUniversity Research in CNS TherapeuticsActivated Protein C Protects Brain CellsPittsburgh Compound Offers a Peep into Alzheimer's DiseaseDrugs in the Pipeline for CNS DisordersCNS Disorder OverviewDrugs in the Pipeline for Alzheimer’s Disease Drugs in the Pipeline for Parkinson’s DiseaseDrugs in the Pipeline for SchizophreniaBipolar Disorder OverviewDrugs in the Pipeline for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in the Pipeline for Autism Drugs in the Pipeline for Sleep Disorders Drugs in the Pipeline--An R&D Analysis (Technical Insights), Drugs in the Pipeline for CancerCorporate Research in CancerCancer Vaccines from Adult Tissue Stem CellsAvi Antisense Drug Boosts Cancer Chemotherapy Genvec Tnf Gene Therapy for Pancreatic CancerPDL Gets License Fees for Humanized AntibodiesAbgenix/Amgen Colorectal Cancer Pivotal ClinicalDendreon Vaccine Extends Prostate Cancer SurvivalAphton Asks Australia for First Cancer Agent OkGenmab Asks for Ok To Start Lymphoma ClinicalsHow Introgen’s INGN 241 Hits CancersLymphoma Therapies Do Well in Clinical TrialsEntremed Compound Stabilizes Multiple MyelomaLymphoma Patients Respond to Genmab MonoclonalKimmel Center Vaccine is Promising in MiceEnzon Negotiates to Develop a Targeted Cancer AgentAllos Sensitizer Aids Brain Metastasis RadiationAGY Therapeutics Finds Brain Cancer TargetAriad Candidate Reduces Brain Tumor Cell GrowthUniversities' Research in CancerProtein Might Contribute to Breast Cancer by Inhibiting Cell GrowthPeptide-based Scaffolds as Drug Delivery VehiclesCancer Drugs in the PipelineGastrointestinal Cancer Drugs in the PipelineBreast Cancer Drugs in the PipelineLung Cancer Drugs in the PipelineProstate Cancer Drugs in the PipelineLymphoma Drugs in the PipelineSkin Cancer Drugs in the PipelineDrugs in the Pipeline--An R&D Analysis (Technical Insights), Patents; Company Listing; Contact DetailsSome Important PatentsPatents Relating to Cardiovascular TherapeuticsPatents Relating to CNS TherapeuticsPatents Related to Cancer TherapeuticsContactsCompaniesUniversities and Research InstitutesDrugs in the Pipeline--An R&D Analysis (Technical Insights), Frost & Sullivan 2004 Science and Technology AwardsTechnology Innovation AwardIntroductionAward RecipientExcellence in Technology AwardIntroductionAward RecipientDrugs in the Pipeline--An R&D Analysis (Technical Insights), Decision Support DatabaseDecision Support DatabasePharmaceutical R&D Expenditure (Million USD)Number of Biotechnology Companies by RegionGovernment Investment in BiotechnologyGovernment R&D Investment in Biotechnology as a Percentage of Total Government Healthcare ExpenditurePrivate Investment in Biotechnology (Million USD)Private Investment in Biotechnology as a Percentage of Total Private Healthcare ExpenditureNumber of European Biotechnology Patents Filed/GrantedNumber of NeurologistsNumber of CardiologistsNumber of Psychiatric Care Hospital Beds




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.